Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses
about
Cardiac electrical activity in a genomically "humanized" chromogranin a monogenic mouse model with hyperadrenergic hypertensionPyroglutamate-amyloid-β and glutaminyl cyclase are colocalized with amyloid-β in secretory vesicles and undergo activity-dependent, regulated secretion.Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease.Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides.Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's diseaseCardiac and hepatic role of r-AtHSP70: basal effects and protection against ischemic and sepsis conditions.Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107Brief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus."Unclassical" Combination of Smell Dysfunction, Altered Abdominal Nociception and Human Hypertension Associated "Classical" Adrenal-Augmentation.The extended granin family: structure, function, and biomedical implicationsAdrenergic genetic mechanisms in hypertension and hypertensive kidney disease.MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.Disorders of blood pressure regulation-role of catecholamine biosynthesis, release, and metabolism.A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders.
P2860
Q33911405-3195DBE1-0C2C-445E-B02D-F4A9061B76C4Q34076284-5BA6A1AB-ADC0-452B-B411-06C867A14BE0Q34435126-13E12882-2826-4B9C-8207-6CD0B8B04742Q34679073-E4D771D4-D427-4A7C-A212-94A0C7BC3D66Q35596997-9702C4FA-1810-450A-BEB6-F6F4C0F00C3DQ35879483-090B573B-43D4-4941-9F22-AA94D792A2CDQ35903118-1BBB78E7-92AB-4853-B613-4D09F2C62F44Q35908640-B97A8ED5-695A-4603-9F19-E4F114EBC495Q36376426-2AC0F5C9-0927-4F46-9DDF-0FCAEC72332CQ36666413-EF285680-AC59-4D94-80A4-2D808036631DQ37089978-FD19CA84-05AF-432D-B784-B51E28E03F9AQ37111953-2AD273C6-E91F-47E4-9C29-245EF436B831Q37954116-AA05A606-413D-4F6E-ADBB-34E438BFBFBCQ42511816-83B7BBBB-D5CE-445D-AD8D-D718D065E92D
P2860
Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effects of chromogranin A defi ...... re and catecholamine responses
@ast
Effects of chromogranin A defi ...... re and catecholamine responses
@en
Effects of chromogranin A defi ...... re and catecholamine responses
@nl
type
label
Effects of chromogranin A defi ...... re and catecholamine responses
@ast
Effects of chromogranin A defi ...... re and catecholamine responses
@en
Effects of chromogranin A defi ...... re and catecholamine responses
@nl
prefLabel
Effects of chromogranin A defi ...... re and catecholamine responses
@ast
Effects of chromogranin A defi ...... re and catecholamine responses
@en
Effects of chromogranin A defi ...... re and catecholamine responses
@nl
P2093
P2860
P1476
Effects of chromogranin A defi ...... re and catecholamine responses
@en
P2093
Daniel T O'Connor
Fangwen Rao
Jiaur Gayen
Michael G Ziegler
Nilima Biswas
Sonia Choksi
Sucheta M Vaingankar
Sushil K Mahata
P2860
P304
P356
10.1097/HJH.0B013E328336ED3E
P577
2010-04-01T00:00:00Z